US Stock MarketDetailed Quotes

Lexeo Therapeutics (LXEO)

Watchlist
  • 5.090
  • -0.410-7.45%
Close May 15 16:00 ET
  • 5.190
  • +0.100+1.96%
Post 20:01 ET
399.68MMarket Cap-4.54P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lexeo Therapeutics (LXEO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-33.94%22.33M
3.30%109.26M
-15.58%23.12M
-31.37%21.65M
30.31%30.69M
45.14%33.81M
54.37%105.77M
82.86%27.38M
55.59%31.54M
68.52%23.55M
Selling and administrative expenses
-60.14%6.63M
43.52%45.46M
-23.40%6.91M
-26.69%5.95M
128.43%15.97M
120.35%16.63M
105.91%31.68M
33.29%9.02M
168.25%8.12M
155.20%6.99M
-General and administrative expense
-60.14%6.63M
43.52%45.46M
-23.40%6.91M
-26.69%5.95M
128.43%15.97M
120.35%16.63M
105.91%31.68M
33.29%9.02M
168.25%8.12M
155.20%6.99M
Research and development costs
-8.55%15.7M
-13.89%63.8M
-11.74%16.21M
-32.99%15.7M
-11.11%14.72M
9.08%17.17M
39.45%74.09M
123.70%18.37M
35.82%23.42M
47.38%16.56M
Operating profit
33.94%-22.33M
-3.30%-109.26M
15.58%-23.12M
31.37%-21.65M
-30.31%-30.69M
-45.14%-33.81M
-54.37%-105.77M
-82.86%-27.38M
-55.59%-31.54M
-68.52%-23.55M
Net non-operating interest income expense
85.43%2.14M
-20.40%5.92M
50.07%2.19M
-33.20%1.37M
-47.73%1.21M
-28.56%1.15M
179.56%7.44M
38.59%1.46M
371.79%2.06M
330.73%2.31M
Non-operating interest income
80.64%2.16M
-19.12%6.13M
48.72%2.21M
-30.40%1.46M
-46.00%1.27M
-27.74%1.19M
164.35%7.58M
35.03%1.49M
328.69%2.09M
297.97%2.35M
Non-operating interest expense
-57.50%17K
50.36%206K
-16.67%25K
134.29%82K
68.57%59K
8.11%40K
-33.17%137K
-40.00%30K
-32.69%35K
-33.96%35K
Other net income (expense)
75.00%-1K
37,566.67%3.37M
9K
-200.00%-9K
337,700.00%3.38M
20.00%-4K
98.34%-9K
0
98.89%-3K
66.67%-1K
Gain on sale of security
----
--3.39M
--0
----
--3.39M
----
----
----
----
----
Other non- operating income (expenses)
75.00%-1K
-100.00%-18K
--9K
-200.00%-9K
-1,300.00%-14K
20.00%-4K
30.77%-9K
--0
-400.00%-3K
66.67%-1K
Income before tax
38.16%-20.2M
-1.66%-99.96M
19.31%-20.92M
31.22%-20.28M
-22.91%-26.1M
-50.61%-32.66M
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
38.16%-20.2M
-1.66%-99.96M
19.31%-20.92M
31.22%-20.28M
-22.91%-26.1M
-50.61%-32.66M
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
Net income continuous Operations
38.16%-20.2M
-1.66%-99.96M
19.31%-20.92M
31.22%-20.28M
-22.91%-26.1M
-50.61%-32.66M
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
Minority interest income
Net income attributable to the parent company
38.16%-20.2M
-1.66%-99.96M
19.31%-20.92M
31.22%-20.28M
-22.91%-26.1M
-50.61%-32.66M
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
38.16%-20.2M
-1.66%-99.96M
19.31%-20.92M
31.22%-20.28M
-22.91%-26.1M
-50.61%-32.66M
-48.11%-98.33M
-82.73%-25.92M
-46.65%-29.49M
-58.01%-21.24M
Basic earnings per share
74.75%-0.25
39.81%-1.86
65.38%-0.27
62.92%-0.33
6.25%-0.6
-28.57%-0.99
75.08%-3.09
-46.50%-0.78
-11.40%-0.89
-19.85%-0.64
Diluted earnings per share
74.75%-0.25
39.81%-1.86
65.38%-0.27
62.92%-0.33
6.25%-0.6
-28.57%-0.99
75.08%-3.09
-46.50%-0.78
-11.40%-0.89
-19.85%-0.64
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -33.94%22.33M3.30%109.26M-15.58%23.12M-31.37%21.65M30.31%30.69M45.14%33.81M54.37%105.77M82.86%27.38M55.59%31.54M68.52%23.55M
Selling and administrative expenses -60.14%6.63M43.52%45.46M-23.40%6.91M-26.69%5.95M128.43%15.97M120.35%16.63M105.91%31.68M33.29%9.02M168.25%8.12M155.20%6.99M
-General and administrative expense -60.14%6.63M43.52%45.46M-23.40%6.91M-26.69%5.95M128.43%15.97M120.35%16.63M105.91%31.68M33.29%9.02M168.25%8.12M155.20%6.99M
Research and development costs -8.55%15.7M-13.89%63.8M-11.74%16.21M-32.99%15.7M-11.11%14.72M9.08%17.17M39.45%74.09M123.70%18.37M35.82%23.42M47.38%16.56M
Operating profit 33.94%-22.33M-3.30%-109.26M15.58%-23.12M31.37%-21.65M-30.31%-30.69M-45.14%-33.81M-54.37%-105.77M-82.86%-27.38M-55.59%-31.54M-68.52%-23.55M
Net non-operating interest income expense 85.43%2.14M-20.40%5.92M50.07%2.19M-33.20%1.37M-47.73%1.21M-28.56%1.15M179.56%7.44M38.59%1.46M371.79%2.06M330.73%2.31M
Non-operating interest income 80.64%2.16M-19.12%6.13M48.72%2.21M-30.40%1.46M-46.00%1.27M-27.74%1.19M164.35%7.58M35.03%1.49M328.69%2.09M297.97%2.35M
Non-operating interest expense -57.50%17K50.36%206K-16.67%25K134.29%82K68.57%59K8.11%40K-33.17%137K-40.00%30K-32.69%35K-33.96%35K
Other net income (expense) 75.00%-1K37,566.67%3.37M9K-200.00%-9K337,700.00%3.38M20.00%-4K98.34%-9K098.89%-3K66.67%-1K
Gain on sale of security ------3.39M--0------3.39M--------------------
Other non- operating income (expenses) 75.00%-1K-100.00%-18K--9K-200.00%-9K-1,300.00%-14K20.00%-4K30.77%-9K--0-400.00%-3K66.67%-1K
Income before tax 38.16%-20.2M-1.66%-99.96M19.31%-20.92M31.22%-20.28M-22.91%-26.1M-50.61%-32.66M-48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M
Income tax 0000000000
Net income 38.16%-20.2M-1.66%-99.96M19.31%-20.92M31.22%-20.28M-22.91%-26.1M-50.61%-32.66M-48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M
Net income continuous Operations 38.16%-20.2M-1.66%-99.96M19.31%-20.92M31.22%-20.28M-22.91%-26.1M-50.61%-32.66M-48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M
Minority interest income
Net income attributable to the parent company 38.16%-20.2M-1.66%-99.96M19.31%-20.92M31.22%-20.28M-22.91%-26.1M-50.61%-32.66M-48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 38.16%-20.2M-1.66%-99.96M19.31%-20.92M31.22%-20.28M-22.91%-26.1M-50.61%-32.66M-48.11%-98.33M-82.73%-25.92M-46.65%-29.49M-58.01%-21.24M
Basic earnings per share 74.75%-0.2539.81%-1.8665.38%-0.2762.92%-0.336.25%-0.6-28.57%-0.9975.08%-3.09-46.50%-0.78-11.40%-0.89-19.85%-0.64
Diluted earnings per share 74.75%-0.2539.81%-1.8665.38%-0.2762.92%-0.336.25%-0.6-28.57%-0.9975.08%-3.09-46.50%-0.78-11.40%-0.89-19.85%-0.64
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -